CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: dienogest
Accession: CHEBI:70708
browse the term
Definition: A steroid hormone that is 17beta-hydroxy-3-oxoestra-4,9-diene substituted at position 17 by a cyanomethyl group. Used as an oral contraceptive.
Synonyms: exact_synonym: [(17beta)-17-hydroxy-3-oxoestra-4,9-dien-17-yl]acetonitrile
related_synonym: (17-hydroxy-3-oxoestra-4,9-dien-17beta-yl)acetonitrile; 17alpha-Cyanomethyl-17beta-hydroxyestra-4,9(10)-dien-3-one; Dienogestum; Formula=C20H25NO2; InChI=1S/C20H25NO2/c1-19-8-6-16-15-5-3-14(22)12-13(15)2-4-17(16)18(19)7-9-20(19,23)10-11-21/h12,17-18,23H,2-10H2,1H3/t17-,18+,19+,20-/m1/s1; InChIKey=AZFLJNIPTRTECV-FUMNGEBKSA-N; SMILES=[H][C@@]12CCC3=CC(=O)CCC3=C1CC[C@@]1(C)[C@@]2([H])CC[C@@]1(O)CC#N
xref: CAS:65928-58-7; Drug_Central:871; KEGG:D03799
xref_mesh: MESH:C023635
xref: PMID:21681516; PMID:22003899; PMID:22067805; PMID:22130322; PMID:22149760; PMID:22160205; PMID:22169052; PMID:22264663; PMID:22322156; PMID:22364708; PMID:22366992; PMID:22413833; PMID:22445438; PMID:22459918; PMID:22515510; PMID:22571602; PMID:22876102; PMID:22878119; PMID:23003209; Patent:EP1935898; Patent:US2008214512; Patent:US2010298585; Patent:US6670350; Patent:WO2008116890; Patent:WO2011132045; Reaxys:5763925; Wikipedia:Dienogest
G
AKR1C1
aldo-keto reductase family 1 member C1
decreases expression
EXP
dienogest results in decreased expression of AKR1C1 mRNA
CTD
PMID:23183084
NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
G
AKR1C2
aldo-keto reductase family 1 member C2
decreases expression
EXP
dienogest results in decreased expression of AKR1C2 mRNA
CTD
PMID:23183084
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
G
CCL2
C-C motif chemokine ligand 2
multiple interactions
EXP
dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein]
CTD
PMID:22014880
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CD4
CD4 molecule
multiple interactions
EXP
[Ethinyl Estradiol co-treated with dienogest] results in decreased expression of CD4 protein
CTD
PMID:10813102
NCBI chr12:6,789,528...6,820,799
Ensembl chr12:6,786,858...6,820,799
G
CRP
C-reactive protein
multiple interactions
EXP
[Estradiol co-treated with dienogest] results in increased expression of CRP protein
CTD
PMID:15970291
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CXCL8
C-X-C motif chemokine ligand 8
multiple interactions
EXP
dienogest inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased expression of CXCL8 mRNA]; dienogest inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased expression of CXCL8 protein]; dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CXCL8 protein]
CTD
PMID:15866594 PMID:22014880
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
decreases expression
EXP
dienogest results in decreased expression of CYP19A1 mRNA; dienogest results in decreased expression of CYP19A1 protein
CTD
PMID:22130322
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
G
F2
coagulation factor II, thrombin
multiple interactions
EXP
[Ethinyl Estradiol co-treated with dienogest] results in increased expression of F2 protein
CTD
PMID:15288212
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
G
F7
coagulation factor VII
multiple interactions
EXP
[Ethinyl Estradiol co-treated with dienogest] results in increased expression of F7 protein
CTD
PMID:15288212
NCBI chr13:113,105,788...113,120,685
Ensembl chr13:113,105,788...113,120,685
G
FGA
fibrinogen alpha chain
multiple interactions
EXP
[Ethinyl Estradiol co-treated with dienogest] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein]
CTD
PMID:15288212
NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742
G
FGB
fibrinogen beta chain
multiple interactions
EXP
[Ethinyl Estradiol co-treated with dienogest] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein]
CTD
PMID:15288212
NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
G
FGG
fibrinogen gamma chain
multiple interactions
EXP
[Ethinyl Estradiol co-treated with dienogest] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein]
CTD
PMID:15288212
NCBI chr 4:154,604,136...154,612,656
Ensembl chr 4:154,604,134...154,612,967
G
FSHB
follicle stimulating hormone subunit beta
decreases expression
EXP
dienogest results in decreased expression of FSHB protein
CTD
PMID:11994349
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
G
HMGB1
high mobility group box 1
multiple interactions
EXP
dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CCL2 protein]; dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of CXCL8 protein]; dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of IL6 protein]; dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of TLR4 mRNA]
CTD
PMID:22014880
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HSD17B2
hydroxysteroid 17-beta dehydrogenase 2
decreases expression
EXP
dienogest results in decreased expression of HSD17B2 mRNA
CTD
PMID:23183084
NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,035,004...82,098,534
G
IGF1
insulin like growth factor 1
multiple interactions
EXP
[Ethinyl Estradiol co-treated with dienogest] results in decreased expression of IGF1 protein
CTD
PMID:11172797
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IL6
interleukin 6
multiple interactions
EXP
dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of IL6 protein]
CTD
PMID:22014880
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
LHB
luteinizing hormone subunit beta
decreases expression
EXP
dienogest results in decreased expression of LHB protein
CTD
PMID:11994349
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
G
NFKB1
nuclear factor kappa B subunit 1
multiple interactions affects localization
EXP
dienogest inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein] dienogest affects the localization of NFKB1 protein
CTD
PMID:15866594 PMID:22130322
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
PLAT
plasminogen activator, tissue type
multiple interactions
EXP
[Ethinyl Estradiol co-treated with dienogest] results in decreased expression of PLAT protein
CTD
PMID:15288212
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
multiple interactions
EXP
[Ethinyl Estradiol co-treated with dienogest] results in increased activity of PROC protein
CTD
PMID:15288212
NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
G
PROS1
protein S
multiple interactions
EXP
[Ethinyl Estradiol co-treated with dienogest] results in decreased expression of PROS1 protein
CTD
PMID:15288212
NCBI chr 3:93,873,051...93,973,896
Ensembl chr 3:93,873,051...93,980,003
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
dienogest results in decreased expression of PTGS2 mRNA; dienogest results in decreased expression of PTGS2 protein
CTD
PMID:22130322
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
SERPINC1
serpin family C member 1
multiple interactions
EXP
[Ethinyl Estradiol co-treated with dienogest] results in decreased activity of SERPINC1 protein
CTD
PMID:15288212
NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327
G
SERPINE1
serpin family E member 1
multiple interactions
EXP
[Ethinyl Estradiol co-treated with dienogest] results in decreased expression of SERPINE1 protein
CTD
PMID:15288212
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
TLR4
toll like receptor 4
multiple interactions
EXP
dienogest inhibits the reaction [[Lipopolysaccharides co-treated with HMGB1 protein] results in increased expression of TLR4 mRNA]
CTD
PMID:22014880
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TNF
tumor necrosis factor
multiple interactions
EXP
dienogest inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased activity of NFKB1 protein]; dienogest inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased expression of CXCL8 mRNA]; dienogest inhibits the reaction [[Estradiol co-treated with TNF protein] results in increased expression of CXCL8 protein]
CTD
PMID:15866594
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all